Uncategorized
Bevacizumab, aflibercept reduce macular edema due to central retinal vein occlusion
NEW YORK (Reuters Health) - Two news studies show that bevacizumab and aflibercept can reduce macular
edema and improve visual acuity in patients with central retinal vein occlusion (CRVO).